Crestline Management LP Buys New Shares in Bowhead Specialty Holdings Inc. (NYSE:BOW)

Crestline Management LP bought a new stake in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 6,716 shares of the company's stock, valued at approximately $239,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Summit Investment Advisors Inc. raised its holdings in Bowhead Specialty by 66.4% during the 4th quarter. Summit Investment Advisors Inc. now owns 1,218 shares of the company's stock valued at $43,000 after acquiring an additional 486 shares during the period. New York State Common Retirement Fund bought a new stake in Bowhead Specialty during the 4th quarter valued at $64,000. US Bancorp DE bought a new stake in Bowhead Specialty during the 4th quarter valued at $76,000. KLP Kapitalforvaltning AS bought a new stake in Bowhead Specialty during the 4th quarter valued at $107,000. Finally, Pictet Asset Management Holding SA bought a new stake in Bowhead Specialty during the 4th quarter valued at $145,000.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. JMP Securities upped their price target on shares of Bowhead Specialty from $38.00 to $40.00 and gave the stock a "market outperform" rating in a report on Friday, April 11th. Piper Sandler assumed coverage on Bowhead Specialty in a research note on Wednesday, April 16th. They issued an "overweight" rating and a $44.00 target price on the stock. JPMorgan Chase & Co. increased their target price on Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a research note on Tuesday, April 8th. Finally, Keefe, Bruyette & Woods increased their target price on Bowhead Specialty from $43.00 to $45.00 and gave the company an "outperform" rating in a research note on Friday, May 9th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Bowhead Specialty presently has a consensus rating of "Moderate Buy" and a consensus price target of $37.50.

Insider Buying and Selling

In other Bowhead Specialty news, Director Ava Schnidman purchased 1,493 shares of the company's stock in a transaction dated Friday, February 28th. The shares were acquired at an average price of $33.41 per share, for a total transaction of $49,881.13. Following the purchase, the director now directly owns 1,893 shares of the company's stock, valued at $63,245.13. The trade was a 373.25% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Bowhead Specialty Stock Performance

Shares of BOW traded down $0.45 on Friday, hitting $38.36. 235,239 shares of the stock traded hands, compared to its average volume of 217,590. The company has a market capitalization of $1.25 billion and a PE ratio of 29.28. The business has a 50 day simple moving average of $39.18 and a 200 day simple moving average of $35.55. Bowhead Specialty Holdings Inc. has a one year low of $22.14 and a one year high of $42.29.

Bowhead Specialty (NYSE:BOW - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.01. The company had revenue of $174.85 million during the quarter, compared to analysts' expectations of $105.17 million. On average, equities analysts expect that Bowhead Specialty Holdings Inc. will post 1.36 earnings per share for the current year.

About Bowhead Specialty

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.